Courses

This CME/CNE program is derived from content presented at the Congress of Clinical Rheumatology 2019. The expert faculty will provide clinicians with an overview of the immunopathogenesis of psoriatic arthritis (PsA). The faculty will analyze the most recent data for the treatment of PsA, highlighting the clinical relevance of both current and emerging therapeutic agents. Managing patients with psoriatic arthritis, ...
View Course

This CME/CNE program will provide a comprehensive update of best practices for treating and managing patients with acute lymphoblastic leukemia (ALL). The expert faculty will outline molecular mutations and patient prognosis, including the t-acute lymphoblastic leukemia and the b-acute lymphoblastic leukemia subtypes. Current clinical trial data will be analyzed, particularly recent breakthroughs in the care of adults with ALL. The ...
View Course

This CME activity will review recent advances in the management of patients with thyroid eye disease (TED) as presented at the International Thyroid Eye Disease Society (ITEDS) 2019 Symposium in Singapore. The expert faculty will discuss the burden of disease for patients with thyroid eye disease, and review the pathophysiology of TED. The faculty will also discuss the latest efficacy ...
View Course

This CME program will highlight recent advanced in the management of patients with atopic dermatitis. Adaobi Nwaneshiudu Obasi, MD, PhD will give a comprehensive review of current clinical trial data of therapeutic options for the treatment of atopic dermatitis. Dr. Obasi will also discuss how to develop effective management strategies with the healthcare team to improve outcomes for patients with atopic dermatitis. At the ...
View Course

This independent CME/CNE lunch symposium, led by Fred D. Lublin, MD, will analyze therapeutic strategies for improving outcomes and reducing disability in patients with multiple sclerosis (MS). The expert faculty will discuss best practices for early detection and monitoring of disease therapy in the MS patient population. The faculty will debate strategies for selecting and switching therapies in the MS ...
View Course

This CME/CNE activity will review recent advances in patients with Bladder Cancer as presented at the American Society of Clinical Oncology- Genitourinary Cancers (ASCO GU) 2019 Symposium in San Francisco, CA. Dr. Richard Lee will inform on clinical decision making for patients with bladder cancer by reviewing the science and tumor microenvironment. He will also discuss the latest clinical treatment options for ...
View Course

This CME/CNE program will provide learners with an update regarding treatment and management of patients with hepatocellular carcinoma (HCC) through an interactive panel format. The expert faculty will first set the stage for modern day HCC care, reviewing the science, prevalence and current treatment guidelines. Recent clinical trial data of first line, second line and combination therapies will be analyzed ...
View Course

This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC). The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. This CE program will include updates from the European Society for Medical Oncology 2018 Congress as well as a review of current relevant ...
View Course

This CME/CNE program will outline recent advances in the treatment and management of  idiopathic pulmonary fibrosis (IPF), incorporating data presented at the 2018 American College of Chest Physicians (CHEST) Annual Meeting in San Antonio, Texas. Three expert faculty, led by Dr. Fernando Martinez, will review and compare recent guidelines/criteria as it relates to therapeutic decision making in the IPF landscape ...
View Course

This CME activity will discuss recent advances in the treatment and management of patients with pulmonary arterial hypertension (PAH). The expert faculty will provide learners with a scientific update regarding current evidence-based guidelines and appropriate diagnostic strategies. Recent clinical trial data of new and emerging therapeutic options for the treatment of PAH will be reviewed. The faculty will also discuss ...
View Course